PharmaCyte Biotech, Inc. (PMCB) stock
PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 7/30
$5.42−0.15 (-2.69%)
Close on Nov 17, 2026Market cap $58.19MP/E –Yield –
PharmaCyte Biotech profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2013 it was -13142.3%, against -2853.6% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2013 | Apr 30, 2013 | -13142.3% | −10288.7 |
| FY2012 | Apr 30, 2012 | -2853.6% | −1744.3 |
| FY2011 | Apr 30, 2011 | -1109.3% | – |
See a number that looks wrong?